|
Sodium azide | CAS 26628-22-8 | ||
NaN3 | RTECS VY8050000 | ||
Synonyms & Trade Names Azide, Azium, Sodium salt of hydrazoic acid |
DOT ID & Guide 1687 153 |
Exposure Limits |
NIOSH REL: C 0.1 ppm (as HN3) [skin] C 0.3 mg/m3 (as NaN3) [skin] | ||
OSHA PEL�: none | |||
IDLH N.D. | Conversion |
Physical Description Colorless to white, odorless, crystalline solid. [pesticide] [Note: Forms hydrazoic acid (HN3) in water.] |
|||
MW: 65.0 |
BP: Decomposes |
MLT: 527°F (Decomposes) |
Sol(63°F): 42% |
VP: ? |
IP: 11.70 eV |
|
Sp.Gr: 1.85 |
Fl.P: ? |
UEL: ? |
LEL: ? |
|
Combustible Solid (if heated above 572°F). | |||
Incompatibilities & Reactivities Acids, metals, water [Note: Over a period of time, sodium azide may react with copper, lead, brass, or solder in plumbing systems to form an accumulation of the HIGHLY EXPLOSIVE compounds of lead azide & copper azide.] |
Measurement Methods OSHA ID121, ID211 |
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
Respirator Recommendations To be added later | |
Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
Symptoms Irritation eyes, skin; headache, dizziness, lassitude (weakness, exhaustion), blurred vision; low blood pressure, bradycardia; kidney changes | |
Target Organs
Eyes, skin, central nervous system, cardiovascular system, kidneys |
See also: INTRODUCTION |